Legislative failures, osteopathy, nutritional advice and more…

FSM news & articles

Therapeutic Goods Amendment Bill 2017 passed by Senate: “…the Government sees no problems with medicines that claims to ‘soften hardness’, ‘tonifies kidney essence’, ‘open body orifices’, ‘replenish the gate of vitality’ and ‘moistens dryness in the triple burner’. ”

New [Read more...]

An invitation to fraud, cancer treatments, the benefits of exercise, and more

 

FSM news & articles

An open invitation to health fraud: Friends of Science in Medicine and other stakeholders are concerned that the Therapeutic Goods Amendment (2017 Measures No. 1) Bill 2017 would remove pre-approval of advertisements for therapeutic goods in favour of self-regulation. The … [Read more...]

Cold cures, placebos, placentophagy, and more…

 

FSM news & articles

Science or Snake Oil: will horseradish and garlic really ease a cold?: Some of us may have heard that horseradish and garlic supplements help ease cold and flu. Blooms High Strength Horseradish and Garlic Complex claims it has. Others, such … [Read more...]

Regulatory failures, unproven stem cell therapy, supplements, and more…

 

FSM news & articles:

The parlous state of consumer protection from healthcare fraud: A call to action from Professor John Dwyer AO, for emergency physicians to promote evidence based medicine and protect consumers from dodgy therapies.

Drug regulator under fire over herbal supplement [Read more...]

Chinese medicine, smoking, flu, and more…

FSM news & articles:

TCM (Traditional Chinese Medicine): New Developments: China is protecting its $40bn Chinese medicine export and sales industry and attempting to grow it and is influencing our country [Australia, but probably many other countries too] through the back door, by giving … [Read more...]

Regulators and complementary medicines, cravings, sweeteners, and more…

FSM news & articles:

New complementary medicine health claims lack evidence, so why are they even on the table?

Friend of Science in Medicine’s Exec member, Prof Ken Harvey on proposed changes to Listed Medicines. Industry proposals have made it to the draft stage, including … [Read more...]